Abstract

It is generally accepted that voltage-gated Ca2+ channels, CaV, regulate Ca2+ homeostasis in excitable cells following plasma membrane depolarization. Here, we show that the Ca2+ protein α1D of CaV1.3 channel is overexpressed in colorectal cancer biopsies compared to normal tissues. Gene silencing experiments targeting α1D reduced the migration and the basal cytosolic Ca2+ concentration of HCT116 colon cancer cell line and modified the cytosolic Ca2+ oscillations induced by the sodium/calcium exchanger NCX1/3 working in its reverse mode. Interestingly, NCX1/3 regulated membrane potential of HCT116 cells only when α1D was silenced, and blocking NCX1/3 increased cytosolic Ca2+ concentration and cell migration. However, membrane depolarization did not induce an increase in intracellular Ca2+. Patch-clamp experiments clearly showed that the inward Ca2+ current was absent. Finally, flow cytometry and immunofluorescence studies showed that α1D protein was localized at the plasma membrane, in cytosol and cell nuclei. Altogether, we uncover a novel signaling pathway showing that α1D is involved in the regulation of Ca2+ homeostasis and cell migration by a mechanism independent of its plasma membrane canonical function but that involved plasma membrane Na+/Ca2+ exchanger.

Details

Title
Ca2+ protein alpha 1D of CaV1.3 regulates intracellular calcium concentration and migration of colon cancer cells through a non-canonical activity
Author
Fourbon, Yann 1 ; Guéguinou, Maxime 2 ; Romain Félix 1 ; Constantin, Bruno 3 ; Uguen, Arnaud 4 ; Fromont, Gaëlle 5 ; Lajoie, Laurie 6 ; Magaud, Christophe 7 ; Lecomte, Thierry 8 ; Chamorey, Emmanuel 9 ; Chatelier, Aurélien 7 ; Mignen, Olivier 10   VIAFID ORCID Logo  ; Potier-Cartereau, Marie 1 ; Chantôme, Aurélie 1 ; Bois, Patrick 7 ; Vandier, Christophe 1 

 Inserm, UMR 1069, Université François Rabelais Tours, Tours, France; Network “Ion channels and cancer-Canceropole Grand Ouest, (IC-CGO), Grand Ouest, France 
 Inserm, UMR 1069, Université François Rabelais Tours, Tours, France; Network “Ion channels and cancer-Canceropole Grand Ouest, (IC-CGO), Grand Ouest, France; Department of Cellular and Molecular Physiology, Penn State University School of Medicine, Hershey Medical Center, Hershey, PA, USA 
 Equipe ERL 7368 CNRS, Université de Poitiers, Poitiers, France; Network “Ion channels and cancer-Canceropole Grand Ouest, (IC-CGO), Grand Ouest, France 
 Inserm UMR 1078 IFR148, Université de Bretagne Occidentale, Brest, France; CHRU Brest, Brest, France 
 Inserm, UMR 1069, Université François Rabelais Tours, Tours, France; CHRU Tours, Tours, France; Network “Ion channels and cancer-Canceropole Grand Ouest, (IC-CGO), Grand Ouest, France 
 GICC– UMR 7292 Université de Tours, Tours, France 
 Equipe ERL 7368 CNRS, Université de Poitiers, Poitiers, France 
 GICC– UMR 7292 Université de Tours, Tours, France; CHRU Tours, Tours, France; Network “Ion channels and cancer-Canceropole Grand Ouest, (IC-CGO), Grand Ouest, France 
 Unité d’Epidémiologie et Biostatistiques (UEB), Centre Antoine Lacassagne, Nice, France 
10  Inserm UMR 1078 IFR148, Université de Bretagne Occidentale, Brest, France; Network “Ion channels and cancer-Canceropole Grand Ouest, (IC-CGO), Grand Ouest, France 
Pages
1-13
Publication year
2017
Publication date
Oct 2017
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1956481443
Copyright
© 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.